5 Worst Stock Picks of Cathie Wood in 2022

In this piece, we will take a look at the five worst stock picks of Cathie Wood in 2022. For her top worst stock picks, head on over to 15 Worst Stock Picks of Cathie Wood in 2022.

5. Surface Oncology Inc. (NASDAQ:SURF)

Negative Percentage Change From 52 Week High: 74.01%

Number of Hedge Fund Holders In Q3 2022: 12

Surface Oncology Inc. (NASDAQ:SURF), as the name suggests, is a biotechnology firm that develops cancer treatments. This includes using T-Cells to deliver therapies and developing antibodies and adenosines to inhibit enzyme activity in the human body.

12 of the 920 hedge funds surveyed by Insider Monkey during 2022’s third quarter had invested in Surface Oncology Inc. (NASDAQ:SURF).

Surface Oncology Inc. (NASDAQ:SURF)’s largest hedge fund investor is Catherine D. Wood’s ARK Investment Management which owns 5.5 million shares worth $4.5 million.

4. XPeng Inc. (NYSE:XPEV)

Negative Percentage Change From 52 Week High: 74.59%

Number of Hedge Fund Holders In Q3 2022: 20

XPeng Inc. (NYSE:XPEV) is a Chinese company that makes and sells electric cars. These include family and sports sedans as well as sport utility vehicles (SUVs). The company is based in Guangzhou, China.

XPeng Inc. (NYSE:XPEV) is broadening its horizon, as it announced in February 2023 that it is launching its G9 SUV and P7 sedans in Europe. Insider Monkey studied 920 hedge fund holdings for last year’s September quarter and found out that 20 had bought XPeng Inc. (NYSE:XPEV)’s shares.

XPeng Inc. (NYSE:XPEV)’s largest investor is Jim Simons’ Renaissance Technologies which owns 6.3 million shares that are worth $75 million.

3. Invitae Corporation (NYSE:NVTA)

Negative Percentage Change From 52 Week High: 78.24%

Number of Hedge Fund Holders In Q3 2022:

Invitae Corporation (NYSE:NVTA) is a healthcare company based in San Francisco, California. The firm provides gene based testing for a variety of different diseases such as cancer and neurological disorders.

Invitae Corporation (NYSE:NVTA) is another firm that saw BlackRock increase its stake in January 2023, as regulatory filings revealed the firm had increased its stake by 24.5% in the healthcare company. 20 of the 920 hedge funds part of Insider Monkey’s Q3 2022 survey had bought Invitae Corporation (NYSE:NVTA)’s shares.

Out of these, Catherine D. Wood’s ARK Investment Management is Invitae Corporation (NYSE:NVTA)’s largest investor. It owns 27 million shares that are worth $50 million.

2. Senti Biosciences, Inc. (NASDAQ:SNTI)

Negative Percentage Change From 52 Week High: 82.20%

Number of Hedge Fund Holders In Q3 2022: 3

Senti Biosciences, Inc. (NASDAQ:SNTI) is another San Francisco based biotechnology firm. It develops genetic and cellular treatments for cancers such as leukemia and carcinoma.

Senti Biosciences, Inc. (NASDAQ:SNTI) is aiming to submit Investigational New Drug (IND) applications to the FDA for its cancer treatments during the second half of this year. As part of their third quarter of 2022 investments, three of the 920 hedge funds polled by Insider Monkey had bought the firm’s shares.

1. Fathom Digital Manufacturing Corporation (NYSE:FATH)

Negative Percentage Change From 52 Week High: 86.09%

Number of Hedge Fund Holders In Q3 2022: 11

Fathom Digital Manufacturing Corporation (NYSE:FATH) is a hardware manufacturing company that provides products for several industries such as aerospace, medical, automotive, and gadget industries.

As part of their third quarter of 2022 investments, 11 of the 920 hedge funds polled by Insider Monkey had bought Fathom Digital Manufacturing Corporation (NYSE:FATH)’s shares.

Disclosure: None. You can also take a peek at 15 Best Cybersecurity Stocks To Buy and 25 Countries That Have the Most Debt Per Capita.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter